Chemoinformaics analysis of 6,6-DIMETHYLBICYCLO[3.1.1]HEPT-2-ENE-2-CARBOXYLIC ACID
Molecular Weight | 166.22 | nRot | 1 |
Heavy Atom Molecular Weight | 152.108 | nRig | 23 |
Exact Molecular Weight | 166.099 | nRing | 3 |
Solubility: LogS | -3.863 | nHRing | 0 |
Solubility: LogP | 0.041 | No. of Aliphatic Rings | 3 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 27.6391 |
nHD | 1 | BPOL | 14.9129 |
QED | 0.243 |
Synth | 3.98 |
Natural Product Likeliness | 2.239 |
NR-PPAR-gamma | 0.943 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.004 |
Pgp-sub | 0.32 |
HIA | 0.793 |
CACO-2 | -6.256 |
MDCK | 0.00000774 |
BBB | 0.013 |
PPB | 0.868164 |
VDSS | 0.866 |
FU | 0.151883 |
CYP1A2-inh | 0.087 |
CYP1A2-sub | 0.045 |
CYP2c19-inh | 0.012 |
CYP2c19-sub | 0.044 |
CYP2c9-inh | 0.038 |
CYP2c9-sub | 0.172 |
CYP2d6-inh | 0.028 |
CYP2d6-sub | 0.158 |
CYP3a4-inh | 0.074 |
CYP3a4-sub | 0.01 |
CL | 5.275 |
T12 | 0.932 |
hERG | 0.029 |
Ames | 0.697 |
ROA | 0.049 |
SkinSen | 0.816 |
Carcinogencity | 0.031 |
EI | 0.313 |
Respiratory | 0.033 |
NR-Aromatase | 0.867 |
Antiviral | No |
Prediction | 0.912983 |